If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Rule 8.4 Disclosure

10 Mar 2009 11:20

RNS Number : 6127O
W.H. Ireland Group PLC
10 March 2009
 



10 March 2009

WH Ireland Group PLC ("WH Ireland")

Rule 8.4 Disclosure

As referred to in the announcement released by WH Ireland and Blue Oar PLC ("Blue Oar") on 2 March 2009, the irrevocable commitment received by WH Ireland from Evolve Capital PLC ("Evolve") (the "Evolve Undertaking") to vote in favour of (or accept) the possible offer by WH Ireland for Blue Oar (the "Possible Offer") in respect of Evolve's entire holding of Blue Oar shares (representing approximately 64.9 per cent. of the existing issued share capital of Blue Oar) ceased to be binding if, inter alia, an announcement of a firm intention to make an offer under Rule 2.5 of the City Code was not made by 12 noon on 9 March 2009.

WH Ireland and Blue Oar further announced on 9 March 2009 that discussions were well advanced and ongoing between the parties and that a further announcement would be made in due course.

As the Evolve Undertaking has now ceased to be binding, WH Ireland announces it no longer has a disclosable interest in the securities of Blue Oar under the provisions of Rule 8.4 of the City Code.

Enquiries:

WH Ireland

Richard Ford

Tel: 020 7220 0475

Oriel Securities Ltd

Tom Durie

Jonathan Walker

Tel: 020 7710 7600

Biddicks (Financial PR to WH Ireland)

Zoe Biddick

Tel: 020 7448 1000

Dealing Disclosure Requirements

The disclosure requirements are set out in more detail in Rule 8 of the Code. In particular, under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 'interested' (directly or indirectly) in one per cent. or more of any class of 'relevant securities' of Blue Oar or WH Ireland, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the offer period otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Blue Oar or WH Ireland, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Blue Oar or WH Ireland by WH Ireland or Blue Oar, or by any of their respective 'associates' (within the meaning of the Code), must also be disclosed by no later than 12.00 p.m. (London time) on the Business Day following the date of the relevant transaction.

A disclosure table giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8 of the Code, you should consult the Panel.

If you are in any doubt as to the application of Rule 8 to you, please contact an independent financial adviser authorised under the Financial Services and Markets Act 2000, consult the Panel's website at www.thetakeoverpanel.org.uk or contact the Panel on telephone number +44 (020) 7638 0129; fax: +44 (020) 7236 7013.

This Announcement does not constitute, or form part of, an offer or invitation to purchase any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPMGGMFMGVGLZM
Date   Source Headline
29th Nov 20217:00 amRNSNotice of Half Year Results
9th Nov 202110:41 amRNSESOT Purchases
26th Oct 20217:00 amRNSESOT Purchases
8th Oct 20217:00 amRNSAppointment of New Chief Financial Officer
21st Sep 20217:00 amRNSDirector Appointment
9th Sep 20217:58 amRNSEmployee Share Plan and PDMR Dealings
9th Sep 20217:00 amRNSESOT Purchases
12th Aug 20216:20 pmRNSResult of AGM
5th Aug 20213:50 pmRNSESOT Purchases
4th Aug 202110:23 amRNSPDMR and PCA shareholdings
26th Jul 20218:54 amRNSIssue of Equity and Total Voting Rights
20th Jul 20217:00 amRNSESOT Purchases
15th Jul 20217:00 amRNSFinal Results and Notice of AGM
5th Jul 20217:00 amRNSUpdate on Final Results
28th Jun 20217:00 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSBoard Change
17th Jun 20217:00 amRNSESOT Purchases
20th May 20217:00 amRNSPDMR and PCA shareholdings
18th May 20217:00 amRNSEmployee Share Option Trust Purchase Plan
4th May 20217:01 amRNSBoard Changes & Participation in NED Share Scheme
4th May 20217:00 amRNSYear End Trading Update
17th Mar 202111:56 amRNSPDMR Dealing
11th Mar 20217:00 amRNSGrant of Options and Issue of Equity
15th Feb 20217:00 amRNSAppointment of NOMAD and Joint Broker
23rd Dec 202011:29 amRNSHolding(s) in Company
23rd Dec 20207:00 amRNSCompletion of Acquisition
22nd Dec 202011:48 amRNSHolding(s) in Company
18th Dec 202010:24 amRNSResult of General Meeting and Total Voting Rights
30th Nov 202010:47 amRNSResult of Placing and Notice of General Meeting
30th Nov 20207:00 amRNSConditional Acquisition & Placing for up to £5.3m
17th Nov 20207:00 amRNSNew Appointment
26th Oct 20207:00 amRNSInterim Results
24th Aug 20207:00 amRNSUpdate on Isle of Man Office
6th Aug 20203:02 pmRNSDirectorate Change
4th Aug 202011:39 amRNSResult of AGM
28th Jul 20201:00 pmRNSAdditional participation in NED Scheme
27th Jul 202012:50 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSPDMR shareholding
24th Jul 20203:22 pmRNSPDMR shareholding
23rd Jul 20201:40 pmRNSNew Remuneration Policy, Issue of Options & Equity
9th Jul 20207:00 amRNSFinal Results and Notice of AGM
2nd Jul 20207:00 amRNSDirectorate Change
29th Jun 20207:00 amRNSUpdate on Isle of Man Office
20th May 20207:00 amRNSBoard Changes
14th May 20203:47 pmRNSGeneral Update re Discussions
20th Apr 20207:00 amRNSResponse to Press Speculation
2nd Apr 20207:00 amRNSYear End Trading Update
27th Jan 20209:59 amRNSHolding(s) in Company
2nd Jan 20201:57 pmRNSHolding(s) in Company
31st Dec 201912:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.